|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Instituto Nacional de Cardiologia Ignacio Chavez |
| Information provided by: | Instituto Nacional de Cardiologia Ignacio Chavez |
| ClinicalTrials.gov Identifier: | NCT00522704 |
Purpose
The purpose of this study is to determine if Effective Extracorporeal Blood Flow(eEBF)has correlation with Access Blood Flow (Qa), when eEBF adjusts with Dynamic Arterial Line Pressure (DALP) in patients with Arteriovenous fistulae in hemodialysis treatment.
| Condition | Intervention |
|
Arteriovenous Fistula |
Other: Dynamic Arterial line Pressure (DALP) |
| MedlinePlus related topics: | Fistulas |
| Study Type: | Observational |
| Study Design: | Screening, Cross-Sectional, Defined Population, Prospective Study |
| Official Title: | Correlation Between Access Blood Flow and Extracorporeal Blood Flow |
| Estimated Enrollment: | 30 |
| Study Start Date: | October 2007 |
| Estimated Study Completion Date: | October 2007 |
Accesses that show a large (>15%) decrement over time in vascular access blood flow are associated with a high risk of thrombosis. Serial measurements of vascular access blood flow predict access thrombosis. At the moment, the measurement of access flow is time consuming, operator dependent, so that it cannot be done with every treatment. We hypothesized that extracorporeal blood flow at pressure of -200 to -260 mmHg in arterial line has correlation with access blood flow and this can be used to estimate access blood flow.
Eligibility
| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Franklin B Mora, M.D. | 593 72 868084 | franklin.mora.bravo@gmail.com |
| Contact: Luis R Mariscal, M.D. | 52 55 55 7932911 ext 1262 | mariscalmd@yahoo.com.mx |
| Mexico, Distrito Federeal | |||||
| Instituto Nacional De Cardiología Ignacio Chávez | Recruiting | ||||
| Mexico City, Distrito Federeal, Mexico, 14080 | |||||
| Contact: Luis R Mariscal, M.D. 52 55 557932911 ext 1262 mariscalmd@yahoo.com.mx | |||||
| Principal Investigator: Franklin B Mora, M.D. | |||||
| Sub-Investigator: Luis R Mariscal, M.D. | |||||
| Instituto Nacional de Cardiologia Ignacio Chavez |
| Principal Investigator: | Franklin B Mora, M.D. | Instituto Nacional de Cardiología Ignacio Chávez |
| Study Chair: | Luis R Mariscal, M.D. | Instituto Nacional de Cardiología Ignacio Chávez |
| Study Chair: | Guadalupe C De la Cruz, R.N. | Instituto Nacional de Cardiología Ignacio Chávez |
| Study Director: | Martha G Franco, M.D., PH.D. | Instituto Nacional de Cardiología Ignacio Chávez |
| Study Chair: | Héctor G Pérez-Grovas, M.D. | Instituto Nacional de Cardiología Ignacio Chávez |
| Study Chair: | Norma Venegas, M.D. | Centro de Hemodiálisis "Mansilla"-Buenos Aires. |
| Study Chair: | Carlos Z Najún, M.D. | Centro de Hemodiálisis-"Mansilla"-Buenos Aires |
More Information
| Study ID Numbers: | INCich-07-08-7403 |
| First Received: | August 28, 2007 |
| Last Updated: | August 29, 2007 |
| ClinicalTrials.gov Identifier: | NCT00522704 |
| Health Authority: | Mexico: Ethics Committee |
|
|
|
|